Compugroup Medical Se Stock Revenue
| COP Stock | EUR 13.96 0.17 1.20% |
Compugroup Medical SE fundamentals help investors to digest information that contributes to Compugroup Medical's financial success or failures. It also enables traders to predict the movement of Compugroup Stock. The fundamental analysis module provides a way to measure Compugroup Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Compugroup Medical stock.
Compugroup |
Compugroup Medical SE Company Revenue Analysis
Compugroup Medical's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Compugroup Medical Revenue | 1.03 B |
Most of Compugroup Medical's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Compugroup Medical SE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Compugroup Medical SE reported 1.03 B of revenue. This is 74.84% lower than that of the Technology sector and 34.28% higher than that of the Health Information Services industry. The revenue for all Germany stocks is 89.13% higher than that of the company.
Compugroup Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Compugroup Medical's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Compugroup Medical could also be used in its relative valuation, which is a method of valuing Compugroup Medical by comparing valuation metrics of similar companies.Compugroup Medical is currently under evaluation in revenue category among its peers.
Compugroup Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.033 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 2.74 B | |||
| Shares Outstanding | 52.23 M | |||
| Shares Owned By Insiders | 50.30 % | |||
| Shares Owned By Institutions | 29.81 % | |||
| Price To Earning | 35.30 X | |||
| Price To Book | 2.99 X | |||
| Price To Sales | 1.76 X | |||
| Revenue | 1.03 B | |||
| Gross Profit | 411.46 M | |||
| EBITDA | 213.99 M | |||
| Net Income | 68.97 M | |||
| Cash And Equivalents | 44.29 M | |||
| Cash Per Share | 0.91 X | |||
| Total Debt | 587.08 M | |||
| Debt To Equity | 132.20 % | |||
| Current Ratio | 0.94 X | |||
| Book Value Per Share | 12.87 X | |||
| Cash Flow From Operations | 165.27 M | |||
| Earnings Per Share | 1.36 X | |||
| Target Price | 51.81 | |||
| Number Of Employees | 8.83 K | |||
| Beta | 1.07 | |||
| Market Capitalization | 2.34 B | |||
| Total Asset | 1.79 B | |||
| Z Score | 1.8 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 0.99 % | |||
| Net Asset | 1.79 B |
About Compugroup Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Compugroup Medical SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Compugroup Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Compugroup Medical SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Compugroup Stock
Compugroup Medical financial ratios help investors to determine whether Compugroup Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Compugroup with respect to the benefits of owning Compugroup Medical security.